A treatment for acne approved by the EU
Author: Florian GuénetPublished on: August 28, 2025Country: Europe
Health

The European Medicines Agency (EMA) has approved the drug Winlevi, based on clascoterone, to treat facial acne in adults and adolescents from age 12, providing a new therapeutic option that reduces skin cells' sensitivity to hormones responsible for excess sebum. This approval offers new hope for patients with severe acne, with strict medical monitoring required.
Read original article
lanouvelletribune.infoStay informed with NewsBoulevard
Get the latest news summaries delivered to your inbox


